Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care
Sponsor
University Hospital, Geneva (Other)
Overall Status
Terminated
CT.gov ID
NCT00303407
Collaborator
(none)
1
17.9
Study Details
Study Description
Brief Summary
To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
Study Design
Study Type:
Observational
Observational Model:
Defined Population
Time Perspective:
Prospective
Study Start Date
:
Jan 1, 2001
Study Completion Date
:
Jul 1, 2002
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
0 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
-
Cancer patients in palliative care
-
Patients fully informed about their condition
-
Signed informed consent
-
No exclusion criteria
Exclusion Criteria:
-
Absence of advanced cancer
-
Cancer previously cured
-
Venous thromboembolism diagnosed within 6 months prior to inclusion
-
Absence of discerning capacity
-
Active anti-thrombotic treatment with heparins or coumarines
-
Thrombocytopenia <50G/l
-
PTT >45sec
-
TP<35%
-
Active bleeding
-
Renal failure <20ml/min
-
Past history of heparin-induced thrombocytopenia
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Center of Continuous Care, chemin de la Savonnière | Collonge-Bellerive (Geneva) | Geneva | Switzerland | 1245 |
Sponsors and Collaborators
- University Hospital, Geneva
Investigators
- Principal Investigator: Catherine Weber, MD, Center of Continuous Care, chemin de la Savonnière 11, CH-1245 Collonge-Bellerive
Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00303407
Other Study ID Numbers:
- SPOT 99/54
First Posted:
Mar 16, 2006
Last Update Posted:
Mar 16, 2006
Last Verified:
Dec 1, 2005